1. A Cost‐Effectiveness Analysis of Nivolumab versus Docetaxel for Advanced Nonsquamous NSCLC Including PD‐L1 Testing. Issue 11 (November 2016) Authors: Matter‐Walstra, Klazien; Schwenkglenks, Matthias; Aebi, Stefan; Dedes, Konstantin; Diebold, Joachim; Pietrini, Mario; Klingbiel, Dirk; von Moos, Roger; Gautschi, Oliver Journal: Journal of thoracic oncology Issue: Volume 11:Issue 11(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early‐onset fluoropyrimidine toxicity. Issue 3 (27th June 2014) Authors: Froehlich, Tanja K.; Amstutz, Ursula; Aebi, Stefan; Joerger, Markus; Largiadèr, Carlo R. Journal: International journal of cancer Issue: Volume 136:Issue 3(2015:Feb. 01) Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity. (August 2015) Authors: Kummer, Dominic; Froehlich, Tanja K; Joerger, Markus; Aebi, Stefan; Sistonen, Johanna; Amstutz, Ursula; Largiadèr, Carlo R Journal: Pharmacogenomics Issue: Volume 16:Number 12(2015) Page Start: 1367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment. (June 2009) Authors: Amstutz, Ursula; Farese, Simone; Aebi, Stefan; Largiadèèr, Carlo R Journal: Pharmacogenomics Issue: Volume 10:Number 6(2009) Page Start: 931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]. Issue 1 (January 2023) Authors: Hasler-Strub, Ursula; Mueller, Andreas; Li, Qiyu; Thuerlimann, Beat; Ribi, Karin; Gerber, Stefan; von Moos, Roger; Fehr, Mathias; Rochlitz, Christoph; Zaman, Khalil; Aebi, Stefan; Hochstrasser, Andreas; Gick, Ute; Baertschi, Daniela; Greuter, Stefan; Schreiber, Alexander; Caspar, Clemens B.; Troj... Journal: Journal of geriatric oncology Issue: Volume 14:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis. (February 2020) Authors: Hamzic, Seid; Kummer, Dominic; Froehlich, Tanja K.; Joerger, Markus; Aebi, Stefan; Palles, Claire; Thomlinson, Ian; Meulendijks, Didier; Schellens, Jan H.M.; García-González, Xandra; López-Fernández, Luis A.; Amstutz, Ursula; Largiadèr, Carlo R. Journal: Pharmacological research Issue: Volume 152(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Letter comments on EJC published article: Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2–positive breast carcinomatous meningitis. (November 2018) Authors: Hofer, Silvia; Aebi, Stefan Journal: European journal of cancer Issue: Volume 103(2018) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Locally advanced breast cancer. (March 2022) Authors: Aebi, Stefan; Karlsson, Per; Wapnir, Irene L. Journal: Breast Issue: Volume 62(2022)Supplement 1 Page Start: S58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗